The AZBio Community came together on December 14th to thank our elected leaders for their support of Arizona's health innovation sector, to share our priorities for 2024, and got insights on what to look for in 2024 from Senator TJ Shope, President Pro Tempore of the Arizona Senate.
Category Archives: Advocacy and Regulations
In Comments to FDA, AdvaMed Maintains Support of Agency’s Authority to Regulate LDTs
WASHINGTON, D.C. – Today, AdvaMedDx submitted comments in response to the Food and Drug Administration’s Proposed Rule: Medical Devices; Laboratory Developed Tests. AdvaMedDx is a division of AdvaMed representing companies that develop in vitro diagnostic (IVD) tests.
AHCCCS Requests Federal Authority To Expand Eligibility for KidsCare
Nearly 10,000 More Children Could Become Eligible for CoverageContinue reading
New Report Explores Latest Best Practices in State Bioscience Economic Development Initiatives
Today, the Biotechnology Innovation Organization (BIO), in partnership with the Council of State Bioscience Associations (CSBA), released a new report on the best practices in state bioscience economic development measures, “The U.S. Biosciences Industry in the States: Best Practices in Innovation, Partnerships, and Job Creation.”Continue reading
BIO-backed bills that would support startups passed by House
Two bills to create a healthy investment environment for biotech startups passed the House late May 30 with overwhelming bipartisan support. The legislation was also supported by the Biotechnology Innovation Organization (BIO).
Continue reading
Patients will lose access to 40% of future medicines because of the IRA, new research finds.
New research released by Vital Transformation (VT) shows that the Inflation Reduction Act (IRA) will stifle the ability of companies to continue research and development across a broad range of therapeutic areas. The effects of the IRA will have a far more serious impact on the development of new medicines than has been reported, according to the research.Continue reading
KOL Conversation: The Impact of the IRA on Oncology Patient Care
Impact of the IRA on Oncology Patient Care features an interview with Dr. Barbara L. McAneny, MD, FASCO, MACP Former President for the American Medical Association and the New Mexico Medical Society (NMMS); and currently CEO, New Mexico Cancer Center.
With Dr. Steve Potts CEO, Anticipate Bioscience.
Impact of the IRA on Oncology Patient Care was recorded on the 26th of May 2023Continue reading
AZ Budget Update: See where Arizona is spending and investing in FY24
Arizona Gov. Katie Hobbs has signed Arizona’s FY24 budget. The state’s $17.8 billion spending plan includes money to prevent homelessness, boost education funding and send tax rebates to parents. It also includes some interesting and, in some cases, surprising additions or omissions. Continue reading
How You Can Impact Arizona’s Innovation Future
Grass roots advocacy is when people engage in the legislative process by sharing their views with their elected leaders. It can take the form of writing or signing on to letters, testifying at hearings, attending town halls, visiting an elected leader at their office; or, here in Arizona, sharing their position on bills at the Legislature using the Request to Speak System. Continue reading
Funding for the Arizona Health Innovation Trust Fund Passes in Senate Appropriations
The Arizona Health Innovation Trust Fund (AHIT) was established in 2022 to develop workforce programs; support small health innovation businesses; and provide other financial support that will drive growth in Arizona’s life science sector. On February 23, 2023, SB1084 was amended to appropriate $50 million in funding for AHIT in Arizona’s FY24 budget and declares that the Legislature intends that the Fund steadily grows to maintain a permanent endowment balance of at least $200 million. The amended bill received a Do Pass as Amended recommendation. SB1084 now moves to consideration by the Senate Rules Committee.Continue reading